Literature DB >> 1672083

Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells.

C L Arteaga, C K Osborne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672083     DOI： 10.1007/978-1-4615-3940-7_14

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  10 in total

1.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 2.  Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.

Authors:  Marco Colleoni; Elisabetta Munzone
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

Review 3.  Antiestrogen action and growth factor regulation.

Authors:  L C Murphy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 4.  Gynecologic effects of tamoxifen: case reports and review of the literature.

Authors:  R M Caputo; L J Copeland
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 5.  Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression.

Authors:  K M Koli; C L Arteaga
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

6.  Analysis of epidermal growth factor receptor mRNA expression by polymerase chain reaction assay in 94 human breast adenocarcinoma tumors.

Authors:  N S Falette; N Artagaveytia; M C Rostan; E Garin; J Y Bobin; S Saez
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.

Authors:  W V Welshons; L H Grady; K S Engler; B M Judy
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.

Authors:  Jinkyoung Kim; Jiyun Lee; Chungyeul Kim; Jinhyuk Choi; Aeree Kim
Journal:  Tumour Biol       Date:  2015-11-18

9.  Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor).

Authors:  R Lu; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.

Authors:  Yvonne S Ziegler; James J Moresco; John R Yates; Ann M Nardulli
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.